DemDaily: Cannabis: The Rocky Road to Legalization
July 16, 2021
On Wednesday, Senate Majority Leader Chuck Schumer (D-NY) introduced legislation to decriminalize marijuana at the federal level.
The legislation, titled the Cannabis Administration and Opportunity Act, and co-sponsored by Senators Cory Booker (D-NJ) and Ron Wyden (D-OR), would remove federal penalties associated with cannabis, expunge nonviolent federal cannabis-related criminal records and begin regulating and taxing the drug.
"This is monumental, because, at long last, we are taking steps in the Senate to right the wrongs of the failed war on drugs...I will use my clout as Majority Leader to make this a priority in the Senate. ... It makes eminent sense to legalize marijuana." - Senator Chuck Schumer |
While the bill directs the US Attorney General to remove marijuana from the federal Controlled Substances Act and allow interstate commerce of legal cannabis products, it would still give the states the power to decide whether they want to legalize or reclassify the drug.

(NORML)
Although originally seen as a Democratic issue, Republican lawmakers across the country have embraced the issue in recent years as red state voters signal their approval of medicinal and recreational use of the psychoactive substance.
Since California became the first state to legalize medical marijuana in 1996, 18 states, two territories and DC have passed legislation or ballot initiatives allowing residents to legally light up on some level.
The "Green Wave" now includes 36 states, DC, and four territories that allow for medicinal use of cannabis products. Marijuana use has been decriminalized to some extent in 31 states and DC, while it remains fully illegal in Kansas, Idaho, Nebraska, South Carolina and Tennessee.
Marijuana is currently classified as a Schedule 1 substance under the federal Controlled Substances Act, putting it in the same category as heroin. The category is reserved for the most tightly restricted drugs which are considered highly addictive and have "no currently accepted medical use."
An estimated 40,000 Americans are in jail because of cannabis-related offenses. |
Another 2020 ballot measure, passed in Mississippi to legalize medical marijuana, was overturned by the state Supreme Court in May on procedural grounds.
In 2021, Connecticut, New Jersey, New Mexico, New York and Virginia passed laws legalizing marijuana for recreational use.
Legislation related to cannabis has been proposed in over 35 states this year, including those sponsored or led by Republicans in at least 10 states.
According to an April 5-11, 2021 poll conducted by the Pew Research Center, 91% of US adults say that marijuana should be legal for medical and/or recreational use. 72% of Democrats and 47% of Republicans supported marijuana legalization for both medical and recreational use (MoE: +/- 2.1%). |

(NORML)
The Marijuana Opportunity, Reinvestment and Expungement (MORE) Act, a bill to decriminalize marijuana, passed the US House of Representatives last December with bipartisan support.
The bill, however, which marked the first time a chamber of Congress approved legislation to end federal marijuana prohibition, was ultimately blocked by the then Republican-controlled US Senate.
On May 28, 2021, the MORE Act was reintroduced in the 117th Congress by Representative Jerrold Nadler, along with fellow Democrats Earl Blumenauer, Sheila Jackson Lee, Hakeem Jeffries and Nydia Velázquez.
While the legislation is likely to pass again in the House, Senator Schumer's version in the Upper Chamber, where Republican Senators are resistant to following the example of their GOP state colleagues, faces an uphill battle. Success, once again, will require the votes of 50 Democratic Senators and ten Republicans to surpass the filibuster threshold.

(Caroline Brehman/CQRollCall)
DemList will keep you informed.
DemList
Connecting You to The Party
Connecting You to Each Other
Kimberly Scott
Publisher
SignUp for the Dailys. Follow on Twitter, Facebook, and Linkedin
Sources: NORML, NCSL, Marijuana Policy Project, Forbes, New York Times